Next Article in Journal
Clinical and Technical Validation of Novel Bite Force Measuring Device for Functional Analysis after Mandibular Reconstruction
Next Article in Special Issue
Role of Endoscopic Ultrasound in the Evaluation of Pancreatic Cystic Neoplasms: A Concise Review
Previous Article in Journal
Artificial Intelligence-Assisted Chest X-ray for the Diagnosis of COVID-19: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Diagnosis and Management of Pancreatic Cysts: A Comprehensive Review of the Literature
 
 
Review
Peer-Review Record

The Role of Magnetic Resonance Imaging (MRI) in the Diagnosis of Pancreatic Cystic Lesions (PCLs)

Diagnostics 2023, 13(4), 585; https://doi.org/10.3390/diagnostics13040585
by Elit Quingalahua 1, Mahmoud M. Al-Hawary 2 and Jorge D. Machicado 3,*
Reviewer 1: Anonymous
Reviewer 2:
Diagnostics 2023, 13(4), 585; https://doi.org/10.3390/diagnostics13040585
Submission received: 14 December 2022 / Revised: 22 January 2023 / Accepted: 3 February 2023 / Published: 5 February 2023
(This article belongs to the Special Issue Diagnosis and Management of Pancreatic Cysts)

Round 1

Reviewer 1 Report

This manuscript title: The role of magnetic resonance imaging (MRI) in the diagnosis of pancreatic cystic lesions (PCLs), makes a revision about the MRI as a diagnostic method.

It is well written and offer an excellent overview about different options that MRI offers to explore the healthiness of the pancreas. However, there are some considerations to check:

1-It is very important to know which different motor of searching have been used. It is not methodology explained to check. A methodology should be included according PRISMA protocol:

METHODS

Eligibility criteria 8 Specify the study characteristics (such as PICO, study design, setting, time frame) and report characteristics (such as years

considered, language, publication status) to be used as criteria for eligibility for the review

Information sources 9 Describe all intended information sources (such as electronic databases, contact with study authors, trial registers or other

grey literature sources) with planned dates of coverage

Search strategy 10 Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be

repeated

* It is strongly recommended that this checklist be read in conjunction with the PRISMA-P Explanation and Elaboration (cite when available) for important clarification on the items. Amendments to a review protocol should be tracked and dated. The copyright for PRISMA-P (including checklist) is held by the PRISMA-P Group and is distributed under a Creative Commons Attribution Licence 4.0.

2-2019 is the last year checked, I suppose because there is not methods to know if this is true. That is the reason to ad a good methods section in a systematic review even if it is only a simple review.

One the methods section will be implemented could be consider to publication.

Comments for author File: Comments.pdf

Author Response

We appreciate the comments from the reviewers. We have responded to each of the queries. Please find our responses in red.

Reviewer 1

This manuscript title: The role of magnetic resonance imaging (MRI) in the diagnosis of pancreatic cystic lesions (PCLs), makes a revision about the MRI as a diagnostic method.

It is well written and offer an excellent overview about different options that MRI offers to explore the healthiness of the pancreas. However, there are some considerations to check:

1-It is very important to know which different motor of searching have been used. It is not methodology explained to check. A methodology should be included according PRISMA protocol:

METHODS

Eligibility criteria 8 Specify the study characteristics (such as PICO, study design, setting, time frame) and report characteristics (such as years

considered, language, publication status) to be used as criteria for eligibility for the review

Information sources 9 Describe all intended information sources (such as electronic databases, contact with study authors, trial registers or other

grey literature sources) with planned dates of coverage

Search strategy 10 Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be

repeated

* It is strongly recommended that this checklist be read in conjunction with the PRISMA-P Explanation and Elaboration (cite when available) for important clarification on the items. Amendments to a review protocol should be tracked and dated. The copyright for PRISMA-P (including checklist) is held by the PRISMA-P Group and is distributed under a Creative Commons Attribution Licence 4.0.

2-2019 is the last year checked, I suppose because there is not methods to know if this is true. That is the reason to ad a good methods section in a systematic review even if it is only a simple review.

One the methods section will be implemented could be consider to publication.

Thank you for the comments and suggestions. A section in how the literature search was conducted has been added to the manuscript (section 3).

Reviewer 2 Report

Language and grammar should be extensively improved. There are some comments, as follows.

 

1. In the “Evolution of MRI on assessment of PCLs” section, “…isotropic image acquisition that offer the highest image resolution…” should be revised as “…isotropic image acquisition that offers the highest image resolution…”.

2. In the “Prevalence of PCLs in MRI” section, in the sentence “The effect of technological improvements in PCL prevalence, was illustrated…”, “,” should be removed.

3. In the “Prevalence of PCLs in MRI” section, the numerical format of the prevalence in Table 1 should be consistent. The number “49.1%” should be revised as “45.9%”. At the same time, please give the reasons for the large variations in PLC prevalence among the observational studies.

4. In the “MRI features of PCLs” section, the full name of “IPMN” should be given.

5. In the “Role of MRI to diagnose specific cyst types” section, “…so cyst diagnosis in clinical practice heavily relies in proper imaging interpretation…” should be revised as “…so cyst diagnosis in clinical practice heavily relies on proper imaging interpretation…”.

6. In the “Role of MRI to diagnose specific cyst types” section, the role of MRI to diagnose retention cyst should be described in more details.

7. In the “Role of MRI to diagnose specific cyst types” section, “…main-duct and mixed-duct IPMNs as compared to BD-IPMN” should be revised as “…main-duct and mixed-duct IPMNs as compared to branch-duct IPMNs”. Meanwhile, the expression of “branch-duct IPMN” and “BD-IPMN” should be consistent.

8. In the “Role of MRI to diagnose specific cyst types” section, the value of “[AUC] 9.95” is wrong.

9. In the “Role of MRI to diagnose specific cyst types” section, “… a small branch-duct IPMNs…” should be revised as “… a small branch-duct IPMN…”.

10. In the “Role of MRI to diagnose specific cyst types” section, “None of these morphologic features is specific of IPMNs…” should be revised as “None of these morphologic features are specific to IPMNs…”.

11. In the “Role of MRI to diagnose specific cyst types” section, “… fibrotic changes noticed on histology” should be revised as “… fibrotic changes noticed in histology”.

12. In the “Role of MRI to diagnose specific cyst types” section, “… at increased risk to develop SCAs should be revised as “… at increased risk of developing SCAs”.

13. In the “Role of MRI to diagnose specific cyst types” section, “…and have thin septations” should be revised as “…and has thin septations”.

14. In the “Role of MRI to diagnose specific cyst types” section, “… that would differentiate it from the other cystic lesions” should be revised as “… that would differentiate them from the other cystic lesions”.

15. In the “Role of MRI to diagnose specific cyst types” section, the full name of “EUS” should be given.

16. In theRole of MRI in detecting advanced neoplasia” section, in the sentence “Several society guidelines have proposed classification systems to risk stratify the malignant potential of mucinous lesions based on the presence of high-risk or worrisome imaging features”, references should be added.

17. In theRole of MRI in detecting advanced neoplasia” section, the full names of “AGA”, “ACG”, and “ACR” should be given.

18. In theMethods to improve evaluation of PCLs with MRI” section, “OR 1.28” should be revised as “OR=1.28”.

19. In theMethods to improve evaluation of PCLs with MRI” section, “…the addition of secretin did not significantly increased ductal communication…” should be revised as “…the addition of secretin did not significantly increase ductal communication…”.

20. In theMethods to improve evaluation of PCLs with MRI” section, the full names of “IV”, “ADC”, and “HGD” should be given.

21. In theMethods to improve evaluation of PCLs with MRI” section, “…also kwon as quantitative imaging …” should be revised as “…also known as quantitative imaging …”.

22. In figure legends, “demonstrate” should be revised as demonstrates”.

23. In Figure 6, “Macrocytic SCA” should be revised as “Macrocystic SCA”, and “9” should be revised as “(”.

Author Response

Thank you for the comments. We have responded to each of the queries. Please find our responses below.

Reviewer 2

  1. In the “Evolution of MRI on assessment of PCLs” section, “…isotropic image acquisition that offer the highest image resolution…” should be revised as “…isotropic image acquisition that offers the highest image resolution…”.

-  Thank you. This has been corrected

  1. In the “Prevalence of PCLs in MRI” section, in the sentence “The effect of technological improvements in PCL prevalence, was illustrated…”, “,” should be removed.

- The “,” has been removed as requested.

  1. In the “Prevalence of PCLs in MRI” section, the numerical format of the prevalence in Table 1 should be consistent. The number “49.1%” should be revised as “45.9%”. At the same time, please give the reasons for the large variations in PLC prevalence among the observational studies.

- Thank you for the comment. The numerical format has been edited to be consistent. The number requested has been corrected. We have made more clear the explanations that may explain the large variations of PCL prevalence among the observational studies.

  1. In the “MRI features of PCLs” section, the full name of “IPMN” should be given.

-  Addressed, thank you

  1. In the “Role of MRI to diagnose specific cyst types” section, “…so cyst diagnosis in clinical practice heavily relies in proper imaging interpretation…” should be revised as “…so cyst diagnosis in clinical practice heavily relies on proper imaging interpretation…”.

-  Thank you. This has been revised.  

  1. In the “Role of MRI to diagnose specific cyst types” section, the role of MRI to diagnose retention cyst should be described in more details.

Thank you for the comment. This has been included in the manuscript. “Pancreatic retention cysts are rare benign lesions that can be found in the setting of chronic pancreatitis, cystic fibrosis, or pancreatic tumors. Mechanistically, these cysts represent a dilated segment of the pancreatic duct due to focal duct obstruction from strictures, mucin plugs, calculi, or tumors. The radiologic appearance of retention cysts has not been widely described and it may be difficult to diagnose these cysts with MRI alone as they share characteristics with other PCLs. In a small study of 16 patients with retention cysts, these lesions were well-defined, round, without solid component hypointense on T1WI images, and hyperintense on T2WI images. These lesions may have thin septations, communication to the main pancreatic duct, and ductal dilation.”

  1. In the “Role of MRI to diagnose specific cyst types” section, “…main-duct and mixed-duct IPMNs as compared to BD-IPMN” should be revised as “…main-duct and mixed-duct IPMNs as compared to branch-duct IPMNs”. Meanwhile, the expression of “branch-duct IPMN” and “BD-IPMN” should be consistent.

This has been edited as requested.

  1. In the “Role of MRI to diagnose specific cyst types” section, the value of “[AUC] 9.95” is wrong.

We appreciate the reviewer’s comment. The AUC value has been changed to 0.95.

  1. In the “Role of MRI to diagnose specific cyst types” section, “… a small branch-duct IPMNs…” should be revised as “… a small branch-duct IPMN…”.

Thanks. This has been revised.

  1. In the “Role of MRI to diagnose specific cyst types” section, “None of these morphologic features is specific of IPMNs…” should be revised as “None of these morphologic features are specific to IPMNs…”.

Thanks. “Is” has been changed for “are”

  1. In the “Role of MRI to diagnose specific cyst types” section, “… fibrotic changes noticed on histology” should be revised as “… fibrotic changes noticed in histology”.

This has been revised.

  1. In the “Role of MRI to diagnose specific cyst types” section, “… at increased risk to develop SCAs” should be revised as “… at increased risk of developing SCAs”.

Addressed, thank you.

  1. In the “Role of MRI to diagnose specific cyst types” section, “…and have thin septations” should be revised as “…and has thin septations”.

This has been corrected.

  1. In the “Role of MRI to diagnose specific cyst types” section, “… that would differentiate it from the other cystic lesions” should be revised as “… that would differentiate them from the other cystic lesions”.

Revised.

  1. In the “Role of MRI to diagnose specific cyst types” section, the full name of “EUS” should be given.

Thanks. Addressed.

  1. In the “Role of MRI in detecting advanced neoplasia” section, in the sentence “Several society guidelines have proposed classification systems to risk stratify the malignant potential of mucinous lesions based on the presence of high-risk or worrisome imaging features”, references should be added.

Thank you. References have been added.

 

  1. In the “Role of MRI in detecting advanced neoplasia” section, the full names of “AGA”, “ACG”, and “ACR” should be given.

This has been provided.

  1. In the “Methods to improve evaluation of PCLs with MRI” section, “OR 1.28” should be revised as “OR=1.28”.

This has been revised as suggested by the reviewer.

  1. In the “Methods to improve evaluation of PCLs with MRI” section, “…the addition of secretin did not significantly increased ductal communication…” should be revised as “…the addition of secretin did not significantly increase ductal communication…”.

Addressed, thank you.

  1. In the “Methods to improve evaluation of PCLs with MRI” section, the full names of “IV”, “ADC”, and “HGD” should be given.

Thank you. This has been provided.

  1. In the “Methods to improve evaluation of PCLs with MRI” section, “…also kwon as quantitative imaging …” should be revised as “…also known as quantitative imaging …”.

Corrected.

  1. In figure legends, “demonstrate” should be revised as “demonstrates”.

This has been revised.

  1. In Figure 6, “Macrocytic SCA” should be revised as “Macrocystic SCA”, and “9” should be revised as “(”.

Addressed, thank you.

 

 

Round 2

Reviewer 1 Report

The article has improved with the changes made in the manuscript.

Reviewer 2 Report

Language should be further improved.

Back to TopTop